Inventor
WENHONG LIU
Inventor
CN
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes17%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%
C12NMicroorganisms or enzymes17%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms17%
G06FElectric digital data processing8%
G09GArrangements or circuits for control of indicating devices using static means to present variable information8%
H10KOrganic electric solid-state devices8%
H10WGeneric packages, interconnections, connectors or other constructional details of devices covered by class h108%
PatentTitleYear
12,286,628Diagnostic kit for metastasis and invasion of breast cancer and use of shRNA molecule for silencing expression of human LINC01614202512,185,610OLED display panel and display apparatus with first and second metal mesh layers202411,873,492Medication and diagnostic kit for inhibiting metastasis and invasion of breast cancer, shRNA molecule for silencing expression of human LINC01614 and application thereof202411,574,589Driving circuit for display panel, display module, compensation method of display module and display device2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2024Patents assigned to BOE TECHNOLOGY GROUP CO LTD (2)· patent assignee history
2023–2024Patents assigned to CHENGDU BOE OPTOELECT TECH CO (2)· patent assignee history
2023–2025Based in CN· patent location history
2024–2025Patents assigned to UNIV ZHEJIANG CHINESE MEDICAL (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BOE TECHNOLOGY GROUP CO LTD | 2 | 2023–2024 |
| CHENGDU BOE OPTOELECT TECH CO | 2 | 2023–2024 |
| UNIV ZHEJIANG CHINESE MEDICAL | 2 | 2024–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| CN | 4 | 2023–2025 |